Data as of Q4 2025 (Dec 31, 2025)

MANGROVE PARTNERS IM, LLC

โ€ขCIK: 1535392โ€ขFiling: Q4 2025

**MANGROVE PARTNERS IM, LLC** manages $1.2B across a diversified portfolio of 371 positions. The fund exhibits significant conviction in its top holdings, notably maintaining substantial allocations to FITBM ($98.5M) and RIO ($79.9M). Further concentration is evident in names such as ATMU ($68.3M) and TEVA ($67.4M). This structure suggests a focused, high-conviction approach within its investment mandate.

Total AUM
$1.2B
QoQ Performance
-9.3%
Positions
358
Top 10 Concentration
48.8%
Latest Filing
Q4 2025

Top Holdings Allocation

INDV
RIO
ATMU
TEVA
INDV8.0%
RIO6.5%
ATMU5.6%
TEVA5.5%
ECVT4.3%
BDX3.9%
ENVA3.7%
FLYW3.4%

๐Ÿ“ˆ Biggest Buys

BDX
BECTON DICKINSON & CO
NEW
3.9% of portfolio
FIS
FIDELITY NATL INFORMATION SV
NEW
2.7% of portfolio
TFX
TELEFLEX INCORPORATED
NEW
2.6% of portfolio
REX
REX AMERICAN RES CORP
+92.8%
2.7% of portfolio
BSOL
BITWISE SOLANA STAKING ETF
NEW
0.8% of portfolio

๐Ÿ“‰ Biggest Sells

ENVA
ENOVA INTL INC
-42.3%
3.7% of portfolio
TEVA
TEVA PHARMACEUTICAL INDS LTD
-7.7%
5.5% of portfolio
CIG
CIA ENERGETICA DE MINAS GERA
-42.9%
0.4% of portfolio
PCG
PG&E CORP
-7.1%
3.2% of portfolio
OTX
OPEN TEXT CORP
-5.6%
2.6% of portfolio

Sector Breakdown

Other98.8%
Consumer0.3%
Technology0.2%
Materials0.2%
Communication0.2%
Financial0.1%
Healthcare0.1%
Real Estate0.1%

๐Ÿšช Exited Positionssold since Q3 2025

โ€”
ECD AUTOMOTIVE DESIGN INC
SOLD
$150.8M
TPD
SOMNIGROUP INTERNATIONAL INC
SOLD
$48.6M
LAUR
LAUREATE EDUCATION INC
SOLD
$37.3M
PTGX
PROTAGONIST THERAPEUTICS INC
SOLD
$31.8M
RZLT
REZOLUTE INC
SOLD
$27.1M
+101 more exited positions

Changes from Q3 2025

NEW128 new positions
โ†‘15 increased
โ†“21 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023